MACM

March Altus Capital Management Portfolio holdings

AUM $16M
1-Year Est. Return 18.92%
This Quarter Est. Return
1 Year Est. Return
+18.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16M
AUM Growth
+$3.05M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
12
New
Increased
Reduced
Closed

Top Buys

1
+$1.93M
2
+$1M
3
+$827K
4
BIIB icon
Biogen
BIIB
+$814K
5
DXCM icon
DexCom
DXCM
+$219K

Top Sells

1
+$1.4M
2
+$1.08M
3
+$318K
4
ALXN
Alexion Pharmaceuticals
ALXN
+$294K

Sector Composition

1 Healthcare 87.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EW icon
1
Edwards Lifesciences
EW
$48.8B
$4.17M 26.11%
103,833
+48,000
ACAD icon
2
Acadia Pharmaceuticals
ACAD
$3.81B
$2.31M 14.47%
72,723
-10,000
PETX
3
DELISTED
Aratana Therapeutics, Inc.
PETX
$2.04M 12.79%
218,515
JNJ icon
4
Johnson & Johnson
JNJ
$455B
$1.54M 9.61%
13,000
DXCM icon
5
DexCom
DXCM
$26.9B
$1.25M 7.79%
56,800
+10,000
LLY icon
6
Eli Lilly
LLY
$763B
$1.07M 6.68%
13,310
-13,500
TSRO
7
DELISTED
TESARO, Inc.
TSRO
$1M 6.27%
+10,000
ZTS icon
8
Zoetis
ZTS
$63.5B
$827K 5.17%
+15,900
BIIB icon
9
Biogen
BIIB
$22.2B
$814K 5.09%
+2,600
ALXN
10
DELISTED
Alexion Pharmaceuticals
ALXN
$760K 4.75%
6,199
-2,400
REGN icon
11
Regeneron Pharmaceuticals
REGN
$69.1B
$201K 1.26%
+500
ALGN icon
12
Align Technology
ALGN
$10.2B
– –
-17,319